YAP1 and hepatocellular carcinoma: A meta-analysis by San et al. revealed that YAP overexpression is associated with worse disease-free survival (DFS) and overall survival (OS) in large datasets of patients with different types of solid tumors, including ovarian, endometrial, breast, colon and hepatocellular carcinomas [59].